Novo Holdings tjente 19,1 mia. kr. i 2017

Novo Holdings, der blandt andet ejer Novo Nordisk, landede et overskud på 19,1 mia. kr. i 2017. Det skete i et år, hvor selskabets life science-investeringer uden for Novo-gruppen gav et afkast på 24 pct.
Novo Holdings, investeringsselskabet bag blandt andet Novo Nordisk, ejes selv af Novo Nordisk Fonden - det øverste selskab i Novo-organisationen. | Photo: Martin Havtorn Petersen/MedWatch
Novo Holdings, investeringsselskabet bag blandt andet Novo Nordisk, ejes selv af Novo Nordisk Fonden - det øverste selskab i Novo-organisationen. | Photo: Martin Havtorn Petersen/MedWatch
AF KEVIN GRØNNEMANN

Pengene vælter ind hos Novo Holdings, som ejer Novo Nordisk, Novozymes, Novo Seeds, Novo Ventures og meget andet. Det står klart, efter at selskabet har offentliggjort sine regnskabstal for 2017.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading